Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer A Chan

Showing results (91-100 of 182) with videos related to

Pageof 19
Sort By:
Plos One|June 16, 2012
Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancerJeffrey A Meyerhardt, Marek Ancukiewicz, Thomas A Abrams, et al.
Endocrine-Related Cancer|May 15, 2023
Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasmsJennifer R Eads, Thorvardur R Halfdanarson, Tim Asmis, et al.
Oncotarget|October 4, 2014
Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicitySuganthi Chittaranjan, Susanna Chan, Cindy Yang, et al.
Pancreas|September 29, 2020
Differential Diagnosis of Diarrhea in Patients With Neuroendocrine TumorsJennifer R Eads, Diane Reidy-Lagunes, Heloisa P Soares, et al.
Cancer Research|September 3, 2009
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinomaYujin Hoshida, Sebastian M B Nijman, Masahiro Kobayashi, et al.
Nature Communications|May 3, 2019
Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factorsShiekh Tanveer Ahmad, Alexandra D Rogers, Myra J Chen, et al.
Cancer Research|July 2, 2015
RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent TumorsXuesong Zhao, Tatyana Ponomaryov, Kimberly J Ornell, et al.
Investigational New Drugs|April 10, 2013
Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patientsDouglas A Rubinson, Howard S Hochster, David P Ryan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complexJune Goto, Delia M Talos, Peter Klein, et al.
The Oncologist|August 3, 2021
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective ReviewDavid L Chan, Emily K Bergsland, Jennifer A Chan, et al.
Pageof 19

Showing results (91-100 of 182) with videos related to

Sort By:
Pageof 19
Plos One|June 16, 2012
Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancerJeffrey A Meyerhardt, Marek Ancukiewicz, Thomas A Abrams, et al.
Endocrine-Related Cancer|May 15, 2023
Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasmsJennifer R Eads, Thorvardur R Halfdanarson, Tim Asmis, et al.
Oncotarget|October 4, 2014
Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicitySuganthi Chittaranjan, Susanna Chan, Cindy Yang, et al.
Pancreas|September 29, 2020
Differential Diagnosis of Diarrhea in Patients With Neuroendocrine TumorsJennifer R Eads, Diane Reidy-Lagunes, Heloisa P Soares, et al.
Cancer Research|September 3, 2009
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinomaYujin Hoshida, Sebastian M B Nijman, Masahiro Kobayashi, et al.
Nature Communications|May 3, 2019
Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factorsShiekh Tanveer Ahmad, Alexandra D Rogers, Myra J Chen, et al.
Cancer Research|July 2, 2015
RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent TumorsXuesong Zhao, Tatyana Ponomaryov, Kimberly J Ornell, et al.
Investigational New Drugs|April 10, 2013
Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patientsDouglas A Rubinson, Howard S Hochster, David P Ryan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complexJune Goto, Delia M Talos, Peter Klein, et al.
The Oncologist|August 3, 2021
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective ReviewDavid L Chan, Emily K Bergsland, Jennifer A Chan, et al.
Pageof 19